Risk factors for rectal bleeding in prostate cancer after radiotherapy with a validation of current rectal dose constraints
Patient-reported rectal bleeding is common after prostate cancer radiotherapy. High BMI was a protective factor against rectal bleeding. No correlation was observed between rectal dose-volume constraints and the occurrence of rectal bleeding, suggesting that a rectal high-dose constraint of V74 Gy ≤12% is an adequate threshold to minimize patient-reported rectal bleeding.
Authors
- Christine Vestergård Madsen (ORCID: https://orcid.org/0000-0002-8314-3888)
- Henrik Dahl Nissen (ORCID: https://orcid.org/0000-0002-5002-5463)
- Ellen L. Schaldemose (ORCID: https://orcid.org/0000-0002-0994-648X)
- Ahmed Hussein Zedan (ORCID: https://orcid.org/0000-0002-8895-6394)
- Lars Fokdal (ORCID: https://orcid.org/0000-0003-4382-4694)
- Martin Berg (ORCID: https://orcid.org/0000-0001-6943-3267)
- Bjarke Mortensen
- Thomas Lars Andersen
Institutions
- Vejle Sygehus (DK)
Publication Details
- Journal
- Acta Oncologica
- Published
- 2025-05-08
- DOI
- https://doi.org/10.2340/1651-226x.2025.42551
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52